Tearclear website screenshot

Tearclear

TearClear Corp. is a clinical-stage ophthalmic pharmaceutical company founded in 2015 that develops a preservative-removing drug delivery platform: a chemical filter built into a conventional multi-dose eye-drop bottle that captures benzalkonium chloride (BAK) at the point of instillation, so the medication stays preserved in the bottle but reaches the ocular surface preservative-free. Its lead candidate TC-002 (latanoprost ophthalmic solution 0.005%) met the primary and all secondary endpoints in the CLEAR Phase 3 pivotal glaucoma trial, with TC-001 (timolol), TC-003 (brimonidine/timolol) and TC-004 (brimonidine) behind it. TearClear ships drug products and delivery hardware, not software: it operates no developer program and publishes no API, SDK or machine-readable contract, and its own corporate domain no longer resolves to a served website.

Tearclear is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Ophthalmology, Drug Delivery, and Life Sciences.

3.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-09-02 · rubric v0.18.0
0 APIs
CompanyPharmaceuticalsOphthalmologyDrug DeliveryLife SciencesMedical DevicesGlaucomaClinical Stage

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-02 · rubric v0.18.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/tearclear: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Tearclear Domain Security

no transport/DNS hardening detected

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Access & Security 1

Authentication, authorization, and security posture

Company 1

The organization behind the API

Other 1

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: tearclear
name: Tearclear
description: 'TearClear Corp. is a clinical-stage ophthalmic pharmaceutical company founded in 2015 that develops a preservative-removing
  drug delivery platform: a chemical filter built into a conventional multi-dose eye-drop bottle that captures benzalkonium
  chloride (BAK) at the point of instillation, so the medication stays preserved in the bottle but reaches the ocular surface
  preservative-free. Its lead candidate TC-002 (latanoprost ophthalmic solution 0.005%) met the primary and all secondary
  endpoints in the CLEAR Phase 3 pivotal glaucoma trial, with TC-001 (timolol), TC-003 (brimonidine/timolol) and TC-004 (brimonidine)
  behind it. TearClear ships drug products and delivery hardware, not software: it operates no developer program and publishes
  no API, SDK or machine-readable contract, and its own corporate domain no longer resolves to a served website.'
url: https://raw.githubusercontent.com/api-evangelist/tearclear/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - security
  generated: '2026-09-02'
  method: derived
specificationVersion: '0.20'
created: '2026-08-29'
modified: '2026-08-29'
tags:
- Company
- Pharmaceuticals
- Ophthalmology
- Drug Delivery
- Life Sciences
- Medical Devices
- Glaucoma
- Clinical Stage
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: LinkedIn
  url: https://www.linkedin.com/company/tearclear
- type: SecondaryMarketListing
  url: https://www.hiive.com/securities/tearclear-stock
- type: DomainSecurity
  url: security/tearclear-domain-security.yml
- type: LLMsTxt
  url: llms/tearclear-llms.txt
x-website-note: 'No `Website` pointer is wired. The company''s registered domain, https://tearclear.com, returned HTTP 403
  on 2026-08-29 over both HTTP and HTTPS with a browser User-Agent, under a TLS certificate for gcam1074.siteground.biz and
  an `x-default-vhost: 1` response header — the domain is no longer provisioned as a virtual host on the SiteGround server
  it points at, and the Internet Archive holds no successful capture after 2024-07-24. The previous `Website` pointer on this
  profile was https://www.hiive.com/securities/tearclear-stock, a secondary-market trading venue listing rather than the company''s
  own web presence; it has been retyped so its live 200 no longer stands in for a website the company does not serve.'
x-enrichment:
  date: '2026-08-29'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: TearClear is a clinical-stage ophthalmic pharmaceutical company whose product is a BAK-removing eye-drop bottle
    filter and the latanoprost/timolol/brimonidine drugs dispensed through it, so there is no software product to expose an
    API on; separately, its own domain tearclear.com now answers 403 from an unprovisioned SiteGround default vhost, and no
    api./developer./docs. subdomain resolves at all.
  evidence:
  - url: https://tearclear.com/
    status: 403
  - url: https://tearclear.com/openapi.json
    status: 403
  - url: https://tearclear.com/.well-known/agent-card.json
    status: 403
  - url: https://api.github.com/orgs/tearclear
    status: 404
  - url: https://www.linkedin.com/company/tearclear
    status: 200
  checked: '2026-08-29'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/tearclear"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/tearclear/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/tearclear/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

A second provider on the same verified email joins the account you already have.